| Net loss | |
| Amortization expense of intangibles and other assets | |
| Depreciation and amortization of property and equipment | |
| (Recovery of) provision for losses on accounts receivable | |
| Amortization of discounts on notes payable | |
| Interest expense in connection with issuance of convertible debt | |
| Common stock issued as compensation | |
| Common stock issued as payment of expenses | |
| Stock option compensation expense | |
| Obligations to issue shares revaluation | |
| Gain on settlement of debt | |
| Gain on settlements of accounts payable | |
| Loss on write-down of construction costs | |
| Derivative gain | |
| Accounts receivable | 0 |
| Inventories | |
| Prepaid expenses and other current assets | 137K |
| Deposits and other non-current assets | |
| Accounts payable | -88K |
| Accrued expenses | 1.85M |
| Net cash used in operating activities | |
| Purchase of property and equipment | -9K |
| Patent costs | |
| Purchase of other assets | |
| Net cash used in investing activities | -559K |
| Repayment of debt obligations | |
| Repayment of capital lease obligations | |
| Net proceeds from exercise of options | 111K |
| Net proceeds from stock offering | |
| Net proceeds from short-term notes | |
| Net cash provided by financing activities | 7.01M |
| Net effect of exchange rate changes on cash | |
| NET DECREASE IN CASH | 5.46M |
| Cash, beginning of period | |
| Cash, end of period | |
| Interest | |
| Equipment acquired through assumption of accounts payable | |
| Common stock issued to settle convertible notes and derivative obligations | |
| Fair value of derivatives issued in conjuction with debt and equity financing | |
| Common stock issued as settlement of obligations of discontinued operations | |